<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04026217</url>
  </required_header>
  <id_info>
    <org_study_id>2745</org_study_id>
    <nct_id>NCT04026217</nct_id>
  </id_info>
  <brief_title>Diaphragm Ultrasound as a Powerful Tool in Managing Acute Hypoxemic Respiratory Failure in Hematological Patients</brief_title>
  <official_title>Evaluation of Diaphragmatic Function in Hematological Patients With Acute Hypoxemic Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Sanitaria-Universitaria Integrata di Udine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Sanitaria-Universitaria Integrata di Udine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute hypoxemic respiratory failure due to parenchymal disfunction is one of the main
      complications of immunocompromised hematological patients. Mechanical ventilation is
      frequently needed and diaphragm activity has to be assessed not to worsen ventilator-induced
      lung injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute hypoxemic respiratory failure due to parenchymal disfunction is one of the main
      complications of immunocompromised hematological patients. In these cohort of patients
      mechanical ventilation is frequently needed in order to restore oxygenation and normocapnia.
      Since every positive-pressure ventilation regimen may potentially determine pulmonary
      complications, due to alteration in pressure and volume lung homeostasis and diaphragm
      activity, also diaphragm function has to be assessed not to worsen ventilator-induced lung
      injury (VILI). Main targets of VILI are pulmonary interstitium and diaphragm.

      Pulmonary interstitium is frequently involved in different mechanism of injury, that derive
      both from induced tidal volume and positive end expiratory pressure (PEEP). Indeed, large
      tidal volumes generated during assisted spontaneous breathing may configure non-protective
      ventilation regimens and the so called &quot;pendelluft phenomenon&quot;, that is the intrinsic flow of
      air within the lung from nondependent to dependent regions without changes in tidal volume,
      may affect inadequate PEEP values.

      Positive-pressure ventilation may also alter diaphragm activity. Recent data show that
      diaphragm disfunction, considered as an enhanced or reduced thickening fraction, occurs in
      about 65% of patients undergoing mechanical ventilation.

      Since the potential harm of positive-pressure ventilation, the optimization of mechanical
      ventilation is pivotal to ensure an adequate time-to-recovery without concurring to the onset
      of further lung and diaphragmatic injury. Neurally Adjusted Ventilatory Assist (NAVA) is a
      recent modality of mechanical ventilation that delivers ventilatory assistance according to
      the respiratory effort of the patient, measured by electrical activity of the diaphragm
      (EAdi). NAVA works proportionally with EAdi values, ensuring a better neuroventilatory
      efficiency compared to other mechanical ventilation modes and also reducing
      patient-ventilator asynchrony. According to these features NAVA protocol may be useful in
      preserving gas exchanges and diaphragm function both in invasive and non-invasive
      ventilation.

      Therefore the evaluation of basal diaphragm activity, the choice of the device for oxygen
      support administration and the setting of ventilatory parameters may influence hospital stay
      and outcome of patients affected by acute hypoxemic respiratory failure.

      The aim of this study is to evaluate the basal diaphragm activity of acute hypoxemic
      respiratory failure patients admitted in Intensive Care Unit (ICU) and to record diaphragm
      activity modifications during the ICU stay in relation to the optimization of medical therapy
      and, if necessary, according to the need of ventilatory support (invasive or non-invasive
      ventilation delivered with NAVA protocol).

      This study intends to register also daily diaphragm thickening fraction, daily arterial blood
      gas analysis, failure frequency of non-invasive ventilation, frequency of tracheal
      intubation, length of mechanical ventilation, length of hospital stay and hospital mortality.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 27, 2019</start_date>
  <completion_date type="Anticipated">May 27, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 27, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragm thickening fraction</measure>
    <time_frame>At ICU admission</time_frame>
    <description>Diaphragm thickening fraction measured with echography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diaphragm thickening fraction</measure>
    <time_frame>From date of enrollment until the date of death from any cause or ICU discharge, assessed up to 36 months</time_frame>
    <description>Diaphragm thickening fraction measured with echography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood gas analysis</measure>
    <time_frame>From date of enrollment until the date of death from any cause or ICU discharge, assessed up to 36 months</time_frame>
    <description>Arterial blood gas analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Failure of non-invasive ventilation</measure>
    <time_frame>From date of enrollment until the date of death from any cause or ICU discharge, assessed up to 36 months</time_frame>
    <description>Failure of non-invasive ventilation according to hospital NIV protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of tracheal intubation</measure>
    <time_frame>From date of enrollment until the date of death from any cause or ICU discharge, assessed up to 36 months</time_frame>
    <description>Tracheal intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of positive-pressure ventilation</measure>
    <time_frame>From date of enrollment until the date of death from any cause or ICU discharge, assessed up to 36 months</time_frame>
    <description>Duration of positive-pressure ventilation (NIV or mechanical ventilation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>From date of in-hospital admission until the date of hospital discharge, assessed up to 36 months</time_frame>
    <description>Hospital length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>From date of in-hospital admission until the date of death from any cause or hospital discharge, assessed up to 36 months</time_frame>
    <description>In-hospital mortality</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Respiratory Failure</condition>
  <condition>Diaphragm Injury</condition>
  <condition>Ultrasound</condition>
  <condition>Mechanical Ventilation Complication</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Hematologic patients with hypoxemic respiratory failure
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypoxemic respiratory failure in hematological patients (PaO2 &lt; 70 mmHg or P/F &lt; 150)

        Exclusion Criteria:

          -  Patients with positive-pressure ventilation regimen of high flow nasal cannula prior
             to ICU admission

          -  Unstable clinical condition (use of vasopressors, acute coronary syndrome...)

          -  Refusal of treatment or informed consent

          -  Agitation (RASS ≥+2) or lack of collaboration (Kelly Matthay ≥ 5)

          -  Multiple organ failure

          -  Enrollment in other study protocols
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luigi Vetrugno, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesiology and Intensive Care Clinic - Department of Medicine - ASUIUD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luigi Vetrugno, Doctor</last_name>
    <phone>+393382873386</phone>
    <email>luigi.vetrugno@asuiud.sanita.fvg.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tiziana Bove, Professor</last_name>
    <phone>+393474785763</phone>
    <email>tiziana.bove@asuiud.sanita.fvg.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Anesthesiology and Intensive Care Clinic - Department of Medicine - ASUIUD</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luigi Vetrugno, Doctor</last_name>
      <phone>+393382873386</phone>
      <email>luigi.vetrugno@asuiud.sanita.fvg.it</email>
    </contact>
    <contact_backup>
      <last_name>Tiziana Bove, Professor</last_name>
      <phone>+393474785763</phone>
      <email>tiziana.bove@asuiud.sanita.fvg.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Azoulay E, Thiéry G, Chevret S, Moreau D, Darmon M, Bergeron A, Yang K, Meignin V, Ciroldi M, Le Gall JR, Tazi A, Schlemmer B. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore). 2004 Nov;83(6):360-70.</citation>
    <PMID>15525848</PMID>
  </reference>
  <reference>
    <citation>Thiéry G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, Lévy V, Fieux F, Moreau D, Le Gall JR, Schlemmer B. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol. 2005 Jul 1;23(19):4406-13.</citation>
    <PMID>15994150</PMID>
  </reference>
  <reference>
    <citation>Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med. 2003 Jan;31(1):104-12.</citation>
    <PMID>12545002</PMID>
  </reference>
  <reference>
    <citation>Boldrini R, Fasano L, Nava S. Noninvasive mechanical ventilation. Curr Opin Crit Care. 2012 Feb;18(1):48-53. doi: 10.1097/MCC.0b013e32834ebd71. Review.</citation>
    <PMID>22186215</PMID>
  </reference>
  <reference>
    <citation>Antonelli M, Conti G, Rocco M, Bufi M, De Blasi RA, Vivino G, Gasparetto A, Meduri GU. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med. 1998 Aug 13;339(7):429-35.</citation>
    <PMID>9700176</PMID>
  </reference>
  <reference>
    <citation>Hess DR. Noninvasive ventilation for acute respiratory failure. Respir Care. 2013 Jun;58(6):950-72. doi: 10.4187/respcare.02319. Review.</citation>
    <PMID>23709194</PMID>
  </reference>
  <reference>
    <citation>Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. Lancet. 2009 Jul 18;374(9685):250-9. doi: 10.1016/S0140-6736(09)60496-7. Review.</citation>
    <PMID>19616722</PMID>
  </reference>
  <reference>
    <citation>Antonelli M, Conti G, Esquinas A, Montini L, Maggiore SM, Bello G, Rocco M, Maviglia R, Pennisi MA, Gonzalez-Diaz G, Meduri GU. A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med. 2007 Jan;35(1):18-25.</citation>
    <PMID>17133177</PMID>
  </reference>
  <reference>
    <citation>Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med. 2003 Dec 15;168(12):1438-44. Epub 2003 Sep 18.</citation>
    <PMID>14500259</PMID>
  </reference>
  <reference>
    <citation>Agarwal R, Handa A, Aggarwal AN, Gupta D, Behera D. Outcomes of noninvasive ventilation in acute hypoxemic respiratory failure in a respiratory intensive care unit in north India. Respir Care. 2009 Dec;54(12):1679-87.</citation>
    <PMID>19961634</PMID>
  </reference>
  <reference>
    <citation>Hernández G, Vaquero C, Colinas L, Cuena R, González P, Canabal A, Sanchez S, Rodriguez ML, Villasclaras A, Fernández R. Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation and Postextubation Respiratory Failure in High-Risk Patients: A Randomized Clinical Trial. JAMA. 2016 Oct 18;316(15):1565-1574. doi: 10.1001/jama.2016.14194. Erratum in: JAMA. 2016 Nov 15;316(19):2047-2048. Erratum in: JAMA. 2017 Feb 28;317(8):858.</citation>
    <PMID>27706464</PMID>
  </reference>
  <reference>
    <citation>Stéphan F, Barrucand B, Petit P, Rézaiguia-Delclaux S, Médard A, Delannoy B, Cosserant B, Flicoteaux G, Imbert A, Pilorge C, Bérard L; BiPOP Study Group. High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic Surgery: A Randomized Clinical Trial. JAMA. 2015 Jun 16;313(23):2331-9. doi: 10.1001/jama.2015.5213.</citation>
    <PMID>25980660</PMID>
  </reference>
  <reference>
    <citation>Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Béduneau G, Delétage-Métreau C, Richard JC, Brochard L, Robert R; FLORALI Study Group; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015 Jun 4;372(23):2185-96. doi: 10.1056/NEJMoa1503326. Epub 2015 May 17.</citation>
    <PMID>25981908</PMID>
  </reference>
  <reference>
    <citation>Frat JP, Ragot S, Girault C, Perbet S, Prat G, Boulain T, Demoule A, Ricard JD, Coudroy R, Robert R, Mercat A, Brochard L, Thille AW; REVA network. Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial. Lancet Respir Med. 2016 Aug;4(8):646-652. doi: 10.1016/S2213-2600(16)30093-5. Epub 2016 May 27.</citation>
    <PMID>27245914</PMID>
  </reference>
  <reference>
    <citation>Corley A, Rickard CM, Aitken LM, Johnston A, Barnett A, Fraser JF, Lewis SR, Smith AF. High-flow nasal cannulae for respiratory support in adult intensive care patients. Cochrane Database Syst Rev. 2017 May 30;5:CD010172. doi: 10.1002/14651858.CD010172.pub2. Review.</citation>
    <PMID>28555461</PMID>
  </reference>
  <reference>
    <citation>Goligher EC, Dres M, Fan E, Rubenfeld GD, Scales DC, Herridge MS, Vorona S, Sklar MC, Rittayamai N, Lanys A, Murray A, Brace D, Urrea C, Reid WD, Tomlinson G, Slutsky AS, Kavanagh BP, Brochard LJ, Ferguson ND. Mechanical Ventilation-induced Diaphragm Atrophy Strongly Impacts Clinical Outcomes. Am J Respir Crit Care Med. 2018 Jan 15;197(2):204-213. doi: 10.1164/rccm.201703-0536OC.</citation>
    <PMID>28930478</PMID>
  </reference>
  <reference>
    <citation>Wait JL, Nahormek PA, Yost WT, Rochester DP. Diaphragmatic thickness-lung volume relationship in vivo. J Appl Physiol (1985). 1989 Oct;67(4):1560-8.</citation>
    <PMID>2676955</PMID>
  </reference>
  <reference>
    <citation>Cohn D, Benditt JO, Eveloff S, McCool FD. Diaphragm thickening during inspiration. J Appl Physiol (1985). 1997 Jul;83(1):291-6.</citation>
    <PMID>9216975</PMID>
  </reference>
  <reference>
    <citation>Goligher EC, Ferguson ND, Brochard LJ. Clinical challenges in mechanical ventilation. Lancet. 2016 Apr 30;387(10030):1856-66. doi: 10.1016/S0140-6736(16)30176-3. Epub 2016 Apr 28. Review.</citation>
    <PMID>27203509</PMID>
  </reference>
  <reference>
    <citation>Contejean A, Lemiale V, Resche-Rigon M, Mokart D, Pène F, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Perez P, Meert AP, Benoit D, Hamidfar R, Darmon M, Jourdain M, Renault A, Schlemmer B, Azoulay E. Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study. Ann Intensive Care. 2016 Dec;6(1):102. doi: 10.1186/s13613-016-0202-0. Epub 2016 Oct 25.</citation>
    <PMID>27783381</PMID>
  </reference>
  <reference>
    <citation>Talmor D, Sarge T, Malhotra A, O'Donnell CR, Ritz R, Lisbon A, Novack V, Loring SH. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med. 2008 Nov 13;359(20):2095-104. doi: 10.1056/NEJMoa0708638. Epub 2008 Nov 11.</citation>
    <PMID>19001507</PMID>
  </reference>
  <reference>
    <citation>Brochard L, Slutsky A, Pesenti A. Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. Am J Respir Crit Care Med. 2017 Feb 15;195(4):438-442. doi: 10.1164/rccm.201605-1081CP.</citation>
    <PMID>27626833</PMID>
  </reference>
  <reference>
    <citation>Carteaux G, Millán-Guilarte T, De Prost N, Razazi K, Abid S, Thille AW, Schortgen F, Brochard L, Brun-Buisson C, Mekontso Dessap A. Failure of Noninvasive Ventilation for De Novo Acute Hypoxemic Respiratory Failure: Role of Tidal Volume. Crit Care Med. 2016 Feb;44(2):282-90. doi: 10.1097/CCM.0000000000001379.</citation>
    <PMID>26584191</PMID>
  </reference>
  <reference>
    <citation>L'Her E, Deye N, Lellouche F, Taille S, Demoule A, Fraticelli A, Mancebo J, Brochard L. Physiologic effects of noninvasive ventilation during acute lung injury. Am J Respir Crit Care Med. 2005 Nov 1;172(9):1112-8. Epub 2005 Aug 4.</citation>
    <PMID>16081548</PMID>
  </reference>
  <reference>
    <citation>Mauri T, Cambiaghi B, Spinelli E, Langer T, Grasselli G. Spontaneous breathing: a double-edged sword to handle with care. Ann Transl Med. 2017 Jul;5(14):292. doi: 10.21037/atm.2017.06.55. Review.</citation>
    <PMID>28828367</PMID>
  </reference>
  <reference>
    <citation>Goligher EC, Kavanagh BP, Rubenfeld GD, Adhikari NK, Pinto R, Fan E, Brochard LJ, Granton JT, Mercat A, Marie Richard JC, Chretien JM, Jones GL, Cook DJ, Stewart TE, Slutsky AS, Meade MO, Ferguson ND. Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. Am J Respir Crit Care Med. 2014 Jul 1;190(1):70-6. doi: 10.1164/rccm.201404-0688OC.</citation>
    <PMID>24919111</PMID>
  </reference>
  <reference>
    <citation>Stenqvist O, Grivans C, Andersson B, Lundin S. Lung elastance and transpulmonary pressure can be determined without using oesophageal pressure measurements. Acta Anaesthesiol Scand. 2012 Jul;56(6):738-47. doi: 10.1111/j.1399-6576.2012.02696.x. Epub 2012 Apr 23.</citation>
    <PMID>22524531</PMID>
  </reference>
  <reference>
    <citation>Hedenstierna G. Esophageal pressure: benefit and limitations. Minerva Anestesiol. 2012 Aug;78(8):959-66. Epub 2012 Jun 14.</citation>
    <PMID>22699701</PMID>
  </reference>
  <reference>
    <citation>Terzi N, Piquilloud L, Rozé H, Mercat A, Lofaso F, Delisle S, Jolliet P, Sottiaux T, Tassaux D, Roesler J, Demoule A, Jaber S, Mancebo J, Brochard L, Richard JC. Clinical review: Update on neurally adjusted ventilatory assist--report of a round-table conference. Crit Care. 2012 Jun 20;16(3):225. doi: 10.1186/cc11297. Review.</citation>
    <PMID>22715815</PMID>
  </reference>
  <reference>
    <citation>Colombo D, Cammarota G, Bergamaschi V, De Lucia M, Corte FD, Navalesi P. Physiologic response to varying levels of pressure support and neurally adjusted ventilatory assist in patients with acute respiratory failure. Intensive Care Med. 2008 Nov;34(11):2010-8. doi: 10.1007/s00134-008-1208-3. Epub 2008 Jul 16.</citation>
    <PMID>18629471</PMID>
  </reference>
  <reference>
    <citation>Schmidt M, Kindler F, Cecchini J, Poitou T, Morawiec E, Persichini R, Similowski T, Demoule A. Neurally adjusted ventilatory assist and proportional assist ventilation both improve patient-ventilator interaction. Crit Care. 2015 Feb 25;19:56. doi: 10.1186/s13054-015-0763-6.</citation>
    <PMID>25879592</PMID>
  </reference>
  <reference>
    <citation>Di Mussi R, Spadaro S, Mirabella L, Volta CA, Serio G, Staffieri F, Dambrosio M, Cinnella G, Bruno F, Grasso S. Impact of prolonged assisted ventilation on diaphragmatic efficiency: NAVA versus PSV. Crit Care. 2016 Jan 5;20:1. doi: 10.1186/s13054-015-1178-0.</citation>
    <PMID>26728475</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 15, 2019</study_first_submitted>
  <study_first_submitted_qc>July 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2019</study_first_posted>
  <last_update_submitted>July 17, 2019</last_update_submitted>
  <last_update_submitted_qc>July 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Sanitaria-Universitaria Integrata di Udine</investigator_affiliation>
    <investigator_full_name>Luigi Vetrugno</investigator_full_name>
    <investigator_title>Luigi Vetrugno, M.D., Anesthesiology and Intensive Care Clinic, Department of Medicine, University of Udine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 27, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/17/NCT04026217/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 27, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/17/NCT04026217/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

